Company intelligence / Profile preview
Fervent Pharmaceuticals
Greenville, North Carolina, United Statesferventpharma.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
FP-101 is currently in Phase 2 clinical trials as a non-hormonal, non-herbal, non-antidepressant treatment for vasomotor symptoms associated with menopause. The company is conducting a randomized, double-blind, placebo-controlled clinical trial designed as a fully decentralized clinical trial (DCT) to evaluate FP-101 versus placebo in peri- and post-menopausal women[10].
- Therapeutic areas
- Women's HealthEndocrinology
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
IQVIA (clinical trial sponsor)[5]
Beyond the preview
Go deeper on Fervent Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fervent Pharmaceuticals.